Please assess the completion status of the following clinical trial:

Trial Title: Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* STEMI within 12 hours of randomization~* Planned treatment with a fibrinolytic agent and aspirin~Exclusion Criteria:~* Intention of performing coronary angiography within 48 hours of fibrinolysis~* Treatment with clopidogrel or ticlopidine within 7 days prior to enrollment, or planned treatment with clopidogrel or ticlopidine.~* Contraindication to fibrinolysis~* Planned use of a glycoprotein IIb/IIIa inhibitor~* Prior CABG~* Evidence of cardiogenic shock or acute pulmonary edema requiring intubation or an intraaortic balloon pump~* Known renal or hepatic insufficiency

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).